A5101417567- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
- COVID-19 diagnosis using AI
- Autoimmune and Inflammatory Disorders Research
- Rheumatoid Arthritis Research and Therapies
- Chronic Lymphocytic Leukemia Research
- Ocular Diseases and Behçet’s Syndrome
National Medical Products Administration
2020-2023
Zhuzhou Central Hospital
2016-2021
Central South University
2016
The detection data of IgM and IgG antibodies in 169 patients with coronavirus disease-2019 (COVID-19) were analyzed to evaluate differences clinical performance between the colloidal gold method chemiluminescence method. In this study, antibody showed a positive conversion earlier (about 1-2 days earlier), rates higher different stages disease, trend declining rate later than For antibody, climbing more quickly No obvious negative-converting tendency was observed within 35 after onset...
To assess the cost-effectiveness of infliximab-containing therapy (ICT) for moderate-to-severe rheumatoid arthritis (RA) in a medium-sized Chinese city.A prospective cohort study comparing ICT (25 patients) versus conventional disease-modified antirheumatic drugs (24 RA was used to ICT.The observed significantly reduced disease activity score 28 joints (coefficient -2.718, p < 0.001), improved EQ-5D 0.453, 0.001) and increased medical costs 1.289, associated with ICT. The incremental ratio...
Coronavirus disease-2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally since its first report and become a worldwide pandemic. In response to outbreak of COVID-19, Center for Medical Device Evaluation, NMPA (CMDE) initiated emergency review approval procedures accelerate process reviewing emergent medical products issued Key Points Technical Review Registration SARS-CoV-2 Antigen/Antibody Tests (Key Points) provide...
Background: This study aimed to evaluate the cost-effectiveness of Anbainuo (ABN) plus methotrexate (MTX) vs. conventional disease-modifying antirheumatic drugs (cDMARDs) in Chinese rheumatoid arthritis (RA) patients.
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 antibody testing an important supplement to nucleic acid testing. In the process of emergency approval, Center for Medical Device Evaluation China National Products Administration released Key Points Technical Review Registration Antigen/Antibody Detection Reagents. Clinical Study Requirement section Point has put forward requirements in terms reference methods...